Literature DB >> 18647181

Intra-arterial milrinone for reversible cerebral vasoconstriction syndrome.

Manon Bouchard1, Steve Verreault, Jean-Luc Gariépy, Nicolas Dupré.   

Abstract

Reversible cerebral vasoconstriction syndrome (RCVS) usually presents with recurrent thunderclap headaches and is characterized by multifocal and reversible vasoconstriction of cerebral arteries that can sometimes evolve to severe cerebral ischemia and stroke. We describe the case of a patient who presented with a clinically typical RCVS and developed focal neurological symptoms and signs despite oral treatment with calcium channel blockers. Within hours of neurological deterioration, she was treated with intra-arterial milrinone, a phosphodiesterase inhibitor, which resulted in a rapid and sustained neurological improvement.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18647181     DOI: 10.1111/j.1526-4610.2008.01211.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  22 in total

1.  Multimodal imaging of reversible cerebral vasoconstriction syndrome: a series of 6 cases.

Authors:  C P Marder; M M Donohue; J R Weinstein; K R Fink
Journal:  AJNR Am J Neuroradiol       Date:  2012-03-15       Impact factor: 3.825

2.  Intra-Arterial Verapamil Treatment in Oral Therapy-Refractory Reversible Cerebral Vasoconstriction Syndrome.

Authors:  J M Ospel; C H Wright; R Jung; L L M Vidal; S Manjila; G Singh; D V Heck; A Ray; K A Blackham
Journal:  AJNR Am J Neuroradiol       Date:  2019-12-26       Impact factor: 3.825

Review 3.  Reversible cerebral vasoconstriction syndrome: a review of recent research.

Authors:  Arnaldo Velez; James S McKinney
Journal:  Curr Neurol Neurosci Rep       Date:  2013-01       Impact factor: 5.081

4.  Quantifying Intra-Arterial Verapamil Response as a Diagnostic Tool for Reversible Cerebral Vasoconstriction Syndrome.

Authors:  J M Sequeiros; J A Roa; R P Sabotin; S Dandapat; S Ortega-Gutierrez; E C Leira; C P Derdeyn; G Bathla; D M Hasan; E A Samaniego
Journal:  AJNR Am J Neuroradiol       Date:  2020-09-17       Impact factor: 3.825

5.  Reversible cerebral vasoconstriction syndrome: an under-recognized clinical emergency.

Authors:  Shih-Pin Chen; Jong-Ling Fuh; Shuu-Jiun Wang
Journal:  Ther Adv Neurol Disord       Date:  2010-05       Impact factor: 6.570

Review 6.  Reversible cerebral vasoconstriction syndrome: a comprehensive update.

Authors:  Ali Mehdi; Rula A Hajj-Ali
Journal:  Curr Pain Headache Rep       Date:  2014-09

Review 7.  Reversible Cerebral Vasoconstriction Syndrome, Part 1: Epidemiology, Pathogenesis, and Clinical Course.

Authors:  T R Miller; R Shivashankar; M Mossa-Basha; D Gandhi
Journal:  AJNR Am J Neuroradiol       Date:  2015-01-15       Impact factor: 3.825

Review 8.  Systematic review of reversible cerebral vasoconstriction syndrome.

Authors:  Ahsan Sattar; Georgios Manousakis; Matthew B Jensen
Journal:  Expert Rev Cardiovasc Ther       Date:  2010-10

Review 9.  Control of blood pressure in hypertensive neurological emergencies.

Authors:  Lisa Manning; Thompson G Robinson; Craig S Anderson
Journal:  Curr Hypertens Rep       Date:  2014-06       Impact factor: 5.369

10.  Glucocorticoid-associated worsening in reversible cerebral vasoconstriction syndrome.

Authors:  Aneesh B Singhal; Mehmet A Topcuoglu
Journal:  Neurology       Date:  2016-12-09       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.